Corgenix Announces Publication of Important Clinical Study on AtherOx Technology
Corgenix Medical Corp announced the issuance of one new European patent for the company’s AtherOx (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).
Read More